Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Powles

Showing results (181-190 of 275) with videos related to

Pageof 28
Sort By:
British Journal of Cancer|August 1, 1990
Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancerA L Jones, M P Williams, T J Powles, et al.
Cancer Research|April 1, 1987
Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and routeM Dowsett, P E Goss, T J Powles, et al.
Journal of the National Cancer Institute|May 20, 1998
Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancerT J Powles, E McCloskey, A H Paterson, et al.
Cancer|January 1, 1980
Circulating levels of pregnancy specific beta 1 glycopretein in patients with testicular, bronchogenic and breast carcinomasJ G Grudzinskas, R C Coombes, J G Ratcliffe, et al.
Lancet (London, England)|May 28, 1994
Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trialR P Kedar, T H Bourne, T J Powles, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1992
Serum markers for primary and recurrent breast cancer: BCM-EIA, CAM 26 and CAM 29D Ricketts, L Hadcocks, M Fitzek, et al.
Radiology|February 1, 1996
Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlationS J Vinnicombe, A D MacVicar, R L Guy, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Endocrine changes with the aromatase inhibitor fadrozole hydrochloride in breast cancerM Dowsett, D Smithers, J Moore, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programmeT J Powles, C R Tillyer, A L Jones, et al.
Lancet (London, England)|January 31, 1981
Sex hormone binding globulin levels and prognosis in early breast cancerA L Harris, I E Smith, M Dowsett, et al.
Pageof 28

Showing results (181-190 of 275) with videos related to

Sort By:
Pageof 28
British Journal of Cancer|August 1, 1990
Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancerA L Jones, M P Williams, T J Powles, et al.
Cancer Research|April 1, 1987
Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and routeM Dowsett, P E Goss, T J Powles, et al.
Journal of the National Cancer Institute|May 20, 1998
Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancerT J Powles, E McCloskey, A H Paterson, et al.
Cancer|January 1, 1980
Circulating levels of pregnancy specific beta 1 glycopretein in patients with testicular, bronchogenic and breast carcinomasJ G Grudzinskas, R C Coombes, J G Ratcliffe, et al.
Lancet (London, England)|May 28, 1994
Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trialR P Kedar, T H Bourne, T J Powles, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1992
Serum markers for primary and recurrent breast cancer: BCM-EIA, CAM 26 and CAM 29D Ricketts, L Hadcocks, M Fitzek, et al.
Radiology|February 1, 1996
Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlationS J Vinnicombe, A D MacVicar, R L Guy, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Endocrine changes with the aromatase inhibitor fadrozole hydrochloride in breast cancerM Dowsett, D Smithers, J Moore, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programmeT J Powles, C R Tillyer, A L Jones, et al.
Lancet (London, England)|January 31, 1981
Sex hormone binding globulin levels and prognosis in early breast cancerA L Harris, I E Smith, M Dowsett, et al.
Pageof 28